tiprankstipranks
Trending News
More News >
Leonardo DRS (DRS)
NASDAQ:DRS

Leonardo Drs (DRS) AI Stock Analysis

Compare
925 Followers

Top Page

DR

Leonardo Drs

(NASDAQ:DRS)

Rating:71Outperform
Price Target:
Leonardo DRS shows strong financial performance and positive earnings sentiment, indicating a solid foundation for growth. However, high valuation metrics and technical indicators suggesting overbought conditions introduce caution. While the company is well-aligned with defense priorities, challenges such as supply chain issues and margin pressures need to be managed.
Positive Factors
Market Position and Opportunities
DRS is in a strong position to capitalize on increased focus on expanding shipbuilding capabilities and throughput.
Shipbuilding and Defense Modernization
The renewed emphasis on shipbuilding, coupled with strong defense tech modernization spending globally, is incrementally positive for DRS.
Negative Factors
Supply Chain Risks
China's ban on germanium export poses a risk to the weapon sights business, although DRS has several years worth of supply on hand.
Valuation
At a ~21.5x EV/2026 EBITDA, DRS is currently trading at a ~3-turn premium to peers, presenting a more balanced risk-reward proposition.

Leonardo Drs (DRS) vs. SPDR S&P 500 ETF (SPY)

Leonardo Drs Business Overview & Revenue Model

Company DescriptionLeonardo DRS, Inc., together with its subsidiaries, provides defense products and technologies in the land, air, sea, space, cyber and security, and commercial domains for military applications. It operates in two segments, Advanced Sensing and Computing, and Integrated Mission Systems. The company offers advanced sensor technologies, including infrared systems and sensors for threat detection and situational awareness; uncooled infrared systems and brownout solutions; airborne, ground vehicle mounted, and dismounted soldier electronic warfare (EW) systems; and EW software and training systems, and intelligence solutions. It also provides computing systems for ground vehicles, ships, and submarines; network and data distribution applications; sensor systems; and networked computing infrastructure on military platform. In addition, the company offers force protection systems, such as solutions for counter-unmanned aerial systems, short-range air defense systems, and active protection systems; and power control, distribution, conversion, and propulsion systems, as well as hybrid electric drive propulsion systems, energy storage, gas turbine packages, nuclear instrumentation and controls, and thermal management and refrigeration equipment. It serves the U.S. military, aerospace and defense prime contractors, government intelligence agencies, and international military customers. The company was founded in 1969 and is based in Arlington, Virginia.
How the Company Makes MoneyLeonardo DRS generates revenue through the sale of its defense electronics and technology solutions to government and military organizations. The company's key revenue streams include contracts for the development and supply of advanced military equipment, such as infrared systems, electronic warfare technology, and integrated mission systems. DRS also benefits from long-term partnerships and contracts with the U.S. Department of Defense and other allied military forces, which provide a steady flow of income. Additionally, the company may engage in research and development projects funded by government grants, further contributing to its earnings.

Leonardo Drs Earnings Call Summary

Earnings Call Date:May 01, 2025
(Q1-2025)
|
% Change Since: 22.86%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Positive
Leonardo DRS reported strong Q1 performance with significant bookings, backlog growth, and strategic alignment with defense priorities. However, challenges related to supply chain disruptions and margin pressures in the ASC segment were noted. The overall business outlook remains positive, supported by robust demand and operational improvements.
Q1-2025 Updates
Positive Updates
Strong Bookings and Backlog
Leonardo DRS secured nearly $1 billion in bookings in Q1, translating to a 1.2 book-to-bill ratio. The company achieved its 13th consecutive quarter with a book-to-bill above 1, increasing the backlog to $8.6 billion.
Remarkable Organic Growth
The company experienced organic growth of 16% in Q1, with profit expansion and improved cash flow, driven by material receipts pulled into the quarter.
Successful Capital Return Initiatives
Leonardo DRS commenced the execution of capital return initiatives with the payment of its first dividend and initial stock repurchases.
Advanced Infrared Sensing Demand
High demand was noted for advanced infrared sensing, electric power and propulsion, and tactical radars, contributing to the company's growth.
Positive Adjusted EBITDA Growth
Adjusted EBITDA in Q1 was $82 million, representing a 17% growth from last year.
Defense Budget Alignment
The company is well-aligned with U.S. defense priorities, particularly in shipbuilding, force protection, and the nuclear triad.
Negative Updates
Supply Chain Challenges
Challenges arose with a sole source optics supplier unable to execute on purchase orders due to China's restrictions on rare earth minerals, impacting profitability.
ASC Margin Pressure
ASC segment margin declined by 130 basis points due to negative contract adjustments and increased germanium costs.
International Program Supplier Issue
A supplier issue on an international program led to increased costs as Leonardo DRS sought alternative germanium sources.
Potential Tariff Impacts
The potential implications of tariffs were discussed, although the company expects relative insulation due to its U.S.-centric operations.
Company Guidance
During the Leonardo DRS First Quarter Fiscal Year 2025 Earnings Conference Call, the company reported strong financial performance, surpassing expectations with a 16% organic growth in revenue and adjusted EBITDA growth of 17%, reaching $82 million. The company's book-to-bill ratio was 1.2, with nearly $1 billion in bookings that increased the backlog to a record $8.6 billion. Leonardo DRS maintained its full-year guidance, projecting revenue between $3.45 billion and $3.525 billion, with an adjusted EBITDA forecast of $435 million to $455 million and adjusted diluted EPS in the range of $1.02 to $1.08. The company highlighted its diversified portfolio, strong demand across its segments, and ongoing capital return initiatives, including dividends and stock repurchases. Despite a dynamic operating environment and challenges such as increased germanium costs, the company expressed confidence in its ability to achieve its 2025 outlook, supported by a robust defense budget and strategic alignment with national defense priorities.

Leonardo Drs Financial Statement Overview

Summary
Leonardo DRS presents strong financial performance with significant revenue growth and stable profitability. The company's low debt levels, strong balance sheet, and excellent cash flow generation enhance its financial robustness. Monitoring liquidity and capital allocation can further consolidate its position.
Income Statement
85
Very Positive
Leonardo DRS has shown strong revenue growth over recent years, with an increase from $2,778 million in 2020 to $3,345 million in TTM (Trailing-Twelve-Months). The gross profit margin has improved to 22.7%, reflecting efficient cost management. The EBIT margin is consistent at 9.3%, and the net profit margin is solid at 7.0%. These metrics indicate robust profitability and operational efficiency, making the income statement a strong point for the company.
Balance Sheet
78
Positive
The company's balance sheet reveals a stable financial position with a debt-to-equity ratio of 0.14, indicating low leverage. The equity ratio stands at 62.8%, highlighting a strong equity base. The return on equity is healthy at 9.1%, showing effective use of shareholder funds. Overall, the balance sheet is solid, though there is room for improvement in liquidity and asset utilization.
Cash Flow
80
Positive
Leonardo DRS demonstrates positive cash flow dynamics with a significant increase in free cash flow to $291 million in TTM. The operating cash flow to net income ratio is 1.70, indicating strong cash generation relative to earnings. The free cash flow growth rate is impressive, highlighting the company's ability to generate surplus cash even after capital expenditures. These factors contribute to a strong cash flow position.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
3.35B3.23B2.83B2.69B2.88B2.78B
Gross Profit
758.00M736.00M648.00M575.00M547.00M494.00M
EBIT
312.00M293.00M231.00M561.00M236.00M181.00M
EBITDA
394.00M376.00M313.00M624.00M293.00M229.00M
Net Income Common Stockholders
234.00M213.00M168.00M405.00M154.00M85.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
380.00M598.00M467.00M306.00M240.00M61.00M
Total Assets
4.10B4.18B3.92B3.68B3.07B2.96B
Total Debt
452.00M458.00M497.00M394.00M490.00M530.00M
Net Debt
72.00M-140.00M30.00M88.00M250.00M469.00M
Total Liabilities
1.52B1.63B1.60B1.55B1.48B1.53B
Stockholders Equity
2.57B2.56B2.33B2.13B1.59B1.43B
Cash FlowFree Cash Flow
291.00M186.00M145.00M-32.00M118.00M69.00M
Operating Cash Flow
398.00M271.00M205.00M33.00M178.00M125.00M
Investing Cash Flow
-106.00M-84.00M-59.00M436.00M39.00M-70.00M
Financing Cash Flow
-72.00M-56.00M15.00M-403.00M-38.00M-80.00M

Leonardo Drs Technical Analysis

Technical Analysis Sentiment
Positive
Last Price45.31
Price Trends
50DMA
40.04
Positive
100DMA
36.23
Positive
200DMA
33.88
Positive
Market Momentum
MACD
1.42
Positive
RSI
61.62
Neutral
STOCH
57.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DRS, the sentiment is Positive. The current price of 45.31 is above the 20-day moving average (MA) of 43.38, above the 50-day MA of 40.04, and above the 200-day MA of 33.88, indicating a bullish trend. The MACD of 1.42 indicates Positive momentum. The RSI at 61.62 is Neutral, neither overbought nor oversold. The STOCH value of 57.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DRS.

Leonardo Drs Risk Analysis

Leonardo Drs disclosed 55 risk factors in its most recent earnings report. Leonardo Drs reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leonardo Drs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$12.76B44.4128.24%0.71%9.87%14.16%
ERERJ
76
Outperform
$9.36B23.5413.36%0.38%22.29%51.90%
DRDRS
71
Outperform
$11.62B50.079.50%0.82%13.58%25.96%
HIHII
71
Outperform
$9.00B16.5212.27%2.35%-1.04%-21.80%
68
Neutral
$10.20B143.33
16.92%
66
Neutral
$4.49B12.225.40%3.71%4.17%-11.97%
57
Neutral
$12.25B-45.38%64.98%-10.52%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DRS
Leonardo Drs
45.31
20.25
80.81%
ERJ
Embraer SA
51.08
24.45
91.81%
HII
Huntington Ingalls
234.08
-7.12
-2.95%
BWXT
BWX Technologies
141.12
49.48
53.99%
RKLB
Rocket Lab USA
26.42
21.62
450.42%
SARO
StandardAero, Inc.
30.20
-2.77
-8.40%

Leonardo Drs Corporate Events

Shareholder Meetings
Leonardo DRS Stockholders Approve Key Proposals at Meeting
Neutral
Jun 5, 2025

On June 4, 2025, Leonardo DRS held its Annual Meeting where stockholders voted on various proposals. The election of directors saw significant support, with most nominees receiving over 250 million votes in favor. Additionally, the advisory resolution on executive compensation and the ratification of Ernst & Young LLP as the independent auditor were approved. An amendment to the company’s certificate of incorporation to remove certain supermajority voting requirements was also passed.

The most recent analyst rating on (DRS) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Leonardo Drs stock, see the DRS Stock Forecast page.

Financial Disclosures
Leonardo DRS Reports Strong Q1 2025 Financial Results
Positive
May 1, 2025

Leonardo DRS reported strong financial results for the first quarter of 2025, ending March 31, with a 16% increase in revenue to $799 million and a 72% rise in net earnings to $50 million compared to the previous year. The company also achieved a book-to-bill ratio of 1.2x with $1 billion in bookings and an $8.6 billion backlog, reflecting robust demand for its products and services. The improved profitability and reduced cash flow usage indicate a solid start to the year, positioning the company well for future growth and shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.